These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 30166628)
1. De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy. Tran Mau-Them F; Guibaud L; Duplomb L; Keren B; Lindstrom K; Marey I; Mochel F; van den Boogaard MJ; Oegema R; Nava C; Masurel A; Jouan T; Jansen FE; Au M; Chen AH; Cho M; Duffourd Y; Lozier E; Konovalov F; Sharkov A; Korostelev S; Urteaga B; Dickson P; Vera M; Martínez-Agosto JA; Begemann A; Zweier M; Schmitt-Mechelke T; Rauch A; Philippe C; van Gassen K; Nelson S; Graham JM; Friedman J; Faivre L; Lin HJ; Thauvin-Robinet C; Vitobello A Genet Med; 2019 Apr; 21(4):1008-1014. PubMed ID: 30166628 [TBL] [Abstract][Full Text] [Related]
2. Neurodevelopmental disorder caused by a truncating de novo variant of IRF2BPL. Qian XH; Liu XY; Zhu ZY; Wang SG; Song XX; Chen G; Wu JY; Tang HD; Cao L Seizure; 2021 Jan; 84():47-52. PubMed ID: 33278788 [TBL] [Abstract][Full Text] [Related]
3. De novo variants of IRF2BPL result in developmental epileptic disorder. Wang Y; Ke Z; Li Y; Qiu M; Liu J; Yang Z; Wen S; Liang M; Chen S Orphanet J Rare Dis; 2024 Mar; 19(1):121. PubMed ID: 38481258 [TBL] [Abstract][Full Text] [Related]
4. IRF2BPL: A new genotype for progressive myoclonus epilepsies. Costa C; Oliver KL; Calvello C; Cameron JM; Imperatore V; Tonelli L; Colavito D; Franceschetti S; Canafoglia L; Berkovic SF; Prontera P Epilepsia; 2023 Aug; 64(8):e164-e169. PubMed ID: 36810721 [TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlations in Polish patients with SCN8A-related epilepsy: A multicentre observational study. Paprocka J; Steinborn B; Krygier M; Winczewska-Wiktor A; Przyslo L; Hutny M; Hoffman-Zacharska D; Mazurkiewicz H; Kochanowska I; Zebrowska J; Zawadzka M; Piasecki L; Mazurkiewicz-Beldzinska M Seizure; 2024 Aug; 120():201-209. PubMed ID: 39047613 [TBL] [Abstract][Full Text] [Related]
6. IRF2BPL gene mutation: Expanding on neurologic phenotypes. Shelkowitz E; Singh JK; Larson A; Elias ER Am J Med Genet A; 2019 Nov; 179(11):2263-2271. PubMed ID: 31432588 [TBL] [Abstract][Full Text] [Related]
7. Expanding the clinical phenotype and genetic spectrum of GEMIN5 disorders: Early-infantile developmental and epileptic encephalopathies. Zhang J; Liu X; Zhu G; Wan L; Liang Y; Li N; Huang M; Yang G Brain Behav; 2024 May; 14(5):e3535. PubMed ID: 38773790 [TBL] [Abstract][Full Text] [Related]
8. NAPB and developmental and epileptic encephalopathy: Description of the electroclinical profile associated with a novel pathogenic variant. Mignon-Ravix C; Riccardi F; Daquin G; Cacciagli P; Lamoureux-Toth S; Villard L; Villeneuve N; Molinari F Epilepsia; 2023 Jun; 64(6):e127-e134. PubMed ID: 37014259 [TBL] [Abstract][Full Text] [Related]
9. IRF2BPL gene variants with dystonia: one new Chinese case report. Yang F; Li H; Dai Y; Zhang R; Zhang JT BMC Neurol; 2023 Jan; 23(1):32. PubMed ID: 36670390 [TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of IRF2BPL in a Taiwanese dystonia cohort: The genotype and phenotype correlation. Chen PS; Chen YF; Chiu JY; Wu MC; Tai CH; Chang YY; Lan MY; Lee NC; Lin CH Ann Clin Transl Neurol; 2024 Jun; 11(6):1557-1566. PubMed ID: 38650104 [TBL] [Abstract][Full Text] [Related]
11. Further evidence of affected females with a heterozygous variant in FGF13 causing X-linked developmental and epileptic encephalopathy 90. Narayanan DL; Majethia P; Shrikiran A; Siddiqui S; Dalal A; Shukla A Eur J Med Genet; 2022 Jan; 65(1):104403. PubMed ID: 34871784 [TBL] [Abstract][Full Text] [Related]
12. Heterozygous variants in SPTBN1 cause intellectual disability and autism. Rosenfeld JA; Xiao R; Bekheirnia MR; Kanani F; Parker MJ; Koenig MK; van Haeringen A; Ruivenkamp C; Rosmaninho-Salgado J; Almeida PM; Sá J; Pinto Basto J; Palen E; Oetjens KF; Burrage LC; Xia F; Liu P; Eng CM; ; Yang Y; Posey JE; Lee BH Am J Med Genet A; 2021 Jul; 185(7):2037-2045. PubMed ID: 33847457 [TBL] [Abstract][Full Text] [Related]
13. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy. Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053 [TBL] [Abstract][Full Text] [Related]
14. Neurodevelopmental disorder associated with IRF2BPL gene mutation: Expanding the phenotype? Skorvanek M; Dusek P; Rydzanicz M; Walczak A; Kosinska J; Kostrzewa G; Brzozowska M; Han V; Dosekova P; Gdovinova Z; Lehotska Z; Lisowski P; Ploski R Parkinsonism Relat Disord; 2019 May; 62():239-241. PubMed ID: 30733140 [No Abstract] [Full Text] [Related]
15. Variants in SCAF4 Cause a Neurodevelopmental Disorder and Are Associated with Impaired mRNA Processing. Fliedner A; Kirchner P; Wiesener A; van de Beek I; Waisfisz Q; van Haelst M; Scott DA; Lalani SR; Rosenfeld JA; Azamian MS; Xia F; Dutra-Clarke M; Martinez-Agosto JA; Lee H; ; Noh GJ; Lippa N; Alkelai A; Aggarwal V; Agre KE; Gavrilova R; Mirzaa GM; Straussberg R; Cohen R; Horist B; Krishnamurthy V; McWalter K; Juusola J; Davis-Keppen L; Ohden L; van Slegtenhorst M; de Man SA; Ekici AB; Gregor A; van de Laar I; Zweier C Am J Hum Genet; 2020 Sep; 107(3):544-554. PubMed ID: 32730804 [TBL] [Abstract][Full Text] [Related]
16. De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias. Helbig KL; Lauerer RJ; Bahr JC; Souza IA; Myers CT; Uysal B; Schwarz N; Gandini MA; Huang S; Keren B; Mignot C; Afenjar A; Billette de Villemeur T; Héron D; Nava C; Valence S; Buratti J; Fagerberg CR; Soerensen KP; Kibaek M; Kamsteeg EJ; Koolen DA; Gunning B; Schelhaas HJ; Kruer MC; Fox J; Bakhtiari S; Jarrar R; Padilla-Lopez S; Lindstrom K; Jin SC; Zeng X; Bilguvar K; Papavasileiou A; Xing Q; Zhu C; Boysen K; Vairo F; Lanpher BC; Klee EW; Tillema JM; Payne ET; Cousin MA; Kruisselbrink TM; Wick MJ; Baker J; Haan E; Smith N; Sadeghpour A; Davis EE; Katsanis N; ; Corbett MA; MacLennan AH; Gecz J; Biskup S; Goldmann E; Rodan LH; Kichula E; Segal E; Jackson KE; Asamoah A; Dimmock D; McCarrier J; Botto LD; Filloux F; Tvrdik T; Cascino GD; Klingerman S; Neumann C; Wang R; Jacobsen JC; Nolan MA; Snell RG; Lehnert K; Sadleir LG; Anderlid BM; Kvarnung M; Guerrini R; Friez MJ; Lyons MJ; Leonhard J; Kringlen G; Casas K; El Achkar CM; Smith LA; Rotenberg A; Poduri A; Sanchis-Juan A; Carss KJ; Rankin J; Zeman A; Raymond FL; Blyth M; Kerr B; Ruiz K; Urquhart J; Hughes I; Banka S; ; Hedrich UBS; Scheffer IE; Helbig I; Zamponi GW; Lerche H; Mefford HC Am J Hum Genet; 2018 Nov; 103(5):666-678. PubMed ID: 30343943 [TBL] [Abstract][Full Text] [Related]
17. [Clinical features of epilepsy in children with IRF2BPL gene variation]. Niu Q; Yang Y; Niu XY; Chen Y; Liu WW; Zhang YH Zhonghua Er Ke Za Zhi; 2021 Jun; 59(6):506-510. PubMed ID: 34102826 [No Abstract] [Full Text] [Related]
18. Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies: 27 new patients and overview of the literature. Bar C; Barcia G; Jennesson M; Le Guyader G; Schneider A; Mignot C; Lesca G; Breuillard D; Montomoli M; Keren B; Doummar D; Billette de Villemeur T; Afenjar A; Marey I; Gerard M; Isnard H; Poisson A; Dupont S; Berquin P; Meyer P; Genevieve D; De Saint Martin A; El Chehadeh S; Chelly J; Guët A; Scalais E; Dorison N; Myers CT; Mefford HC; Howell KB; Marini C; Freeman JL; Nica A; Terrone G; Sekhara T; Lebre AS; Odent S; Sadleir LG; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R Hum Mutat; 2020 Jan; 41(1):69-80. PubMed ID: 31513310 [TBL] [Abstract][Full Text] [Related]
19. Epileptic Encephalopathies as Neurodegenerative Disorders. Helbig I; von Deimling M; Marsh ED Adv Neurobiol; 2017; 15():295-315. PubMed ID: 28674986 [TBL] [Abstract][Full Text] [Related]
20. De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis. Weng PL; Majmundar AJ; Khan K; Lim TY; Shril S; Jin G; Musgrove J; Wang M; Ahram DF; Aggarwal VS; Bier LE; Heinzen EL; Onuchic-Whitford AC; Mann N; Buerger F; Schneider R; Deutsch K; Kitzler TM; Klämbt V; Kolb A; Mao Y; Moufawad El Achkar C; Mitrotti A; Martino J; Beck BB; Altmüller J; Benz MR; Yano S; Mikati MA; Gunduz T; Cope H; Shashi V; ; Trachtman H; Bodria M; Caridi G; Pisani I; Fiaccadori E; AbuMaziad AS; Martinez-Agosto JA; Yadin O; Zuckerman J; Kim A; ; John-Kroegel U; Tyndall AV; Parboosingh JS; Innes AM; Bierzynska A; Koziell AB; Muorah M; Saleem MA; Hoefele J; Riedhammer KM; Gharavi AG; Jobanputra V; Pierce-Hoffman E; Seaby EG; O'Donnell-Luria A; Rehm HL; Mane S; D'Agati VD; Pollak MR; Ghiggeri GM; Lifton RP; Goldstein DB; Davis EE; Hildebrandt F; Sanna-Cherchi S Am J Hum Genet; 2021 Feb; 108(2):357-367. PubMed ID: 33508234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]